VCIM

Velan Capital Investment Management Portfolio holdings

AUM $106M
1-Year Est. Return 171.31%
This Quarter Est. Return
1 Year Est. Return
+171.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$106M
AUM Growth
+$6.52M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
61
New
Increased
Reduced
Closed

Top Buys

1
+$5.47M
2
+$4.28M
3
+$3.77M
4
NSPR icon
InspireMD
NSPR
+$2.99M
5
JSPR icon
Jasper Therapeutics
JSPR
+$2.87M

Top Sells

1
+$18.6M
2
+$8.99M
3
+$6.3M
4
ARVN icon
Arvinas
ARVN
+$3.68M
5
SCPH
scPharmaceuticals
SCPH
+$3.5M

Sector Composition

1 Healthcare 95.98%
2 Consumer Discretionary 4.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCPH
51
DELISTED
scPharmaceuticals
SCPH
– –
-917,668
VRNA
52
DELISTED
Verona Pharma
VRNA
– –
-95,000
VYNE icon
53
VYNE Therapeutics
VYNE
$11.9M
– –
-30,000
ZVRA icon
54
Zevra Therapeutics
ZVRA
$460M
– –
-715,000
UPB
55
Upstream Bio Inc
UPB
$1.35B
– –
-107,000
ARVN icon
56
Arvinas
ARVN
$749M
– –
-500,000
CATX icon
57
Perspective Therapeutics
CATX
$152M
– –
-500,000
FDMT icon
58
4D Molecular Therapeutics
FDMT
$579M
– –
-12,000
KPRX icon
59
Kiora Pharmaceuticals
KPRX
$6.95M
– –
-122,223
LQDA icon
60
Liquidia Corp
LQDA
$2.68B
– –
-239,260
NKTR icon
61
Nektar Therapeutics
NKTR
$1.12B
– –
0
1 2
3